Stock data

和迅 (6986)

和迅 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$16.75M, down 22.7% from a year earlier. EPS over the last four quarters totals NT$2.52.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 和迅 in Insightr